Infliximab Pharmacokinetics are Influenced by Intravenous Immunoglobulin Administration in Patients with Kawasaki Disease

被引：0
|
作者：
Niels Vande Casteele
Jun Oyamada
Chisato Shimizu
Brookie M. Best
Edmund V. Capparelli
Adriana H. Tremoulet
Jane C. Burns
机构：
[1] University of California San Diego,Department of Medicine
[2] University of California San Diego,Department of Pediatrics
来源：
Clinical Pharmacokinetics | 2018年 / 57卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1593 / 1601
页数：8
相关论文
共 50 条
  • [41] Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report
    Robert J Brogan
    Despina Eleftheriou
    James Gnanapragasam
    Nigel J Klein
    Paul A Brogan
    Pediatric Rheumatology, 7
  • [42] Endothelial Cell Response to Intravenous Immunoglobulin, Infliximab and Atorvastatin Treatment During the Acute Phase of Kawasaki Disease
    Shimizu, Chisato
    Kim, Jihoon
    He, Ming
    Hoffman, Hal
    Shyy, John
    Burns, Jane
    Tremoulet, Adriana H.
    CIRCULATION, 2021, 144
  • [43] Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report
    Brogan, Robert J.
    Eleftheriou, Despina
    Gnanapragasam, James
    Klein, Nigel J.
    Brogan, Paul A.
    PEDIATRIC RHEUMATOLOGY, 2009, 7
  • [44] The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease
    Roberts, Samantha C.
    Jain, Sonia
    Tremoulet, Adriana H.
    Kim, Katherine K.
    Burns, Jane C.
    Anand, Vikram
    Anderson, Marsha
    Ang, Jocelyn
    Ansusinha, Emily
    Arditi, Moshe
    Ashouri, Negar
    Bartlett, Allison
    Chatterjee, Archana
    DeBiasi, Roberta
    Dekker, Cornelia
    DeZure, Chandani
    Didion, Lisa
    Dominguez, Samuel
    El Feghaly, Rana
    Erdem, Guliz
    Halasa, Natasha
    Harahsheh, Ashraf
    Jackson, Mary Anne
    Jaggi, Preeti
    Jain, Supriya
    Jone, Pei-Ni
    Kaushik, Neeru
    Kurio, Gregory
    Lillian, Anna
    Lloyd, David
    Manaloor, John
    McNelis, Amy
    Michalik, David E.
    Newburger, Jane
    Newcomer, Charles
    Perkins, Tiffany
    Portman, Michael
    Romero, Jose
    Ronis, Tova
    Rowley, Anne
    Schneider, Kathryn
    Schuster, Jennifer
    Tejtel, S. Kristen Sexson
    Sharma, Kavita
    Simonsen, Kari
    Szmuszkovicz, Jacqueline
    Truong, Dongngan
    Wood, James
    Yeh, Sylvia
    CONTEMPORARY CLINICAL TRIALS, 2019, 79 : 98 - 103
  • [45] Impact of infliximab administration before plasma exchange therapy on patients with Kawasaki disease
    Shimada, Shun
    Matsuoka, Daisuke
    Murase, Tsubasa
    Hachiya, Akira
    Motoki, Noriko
    Nakazawa, Yozo
    THERAPEUTIC APHERESIS AND DIALYSIS, 2020, 24 (06) : 718 - 724
  • [46] Infliximab administration effective in the treatment of refractory Kawasaki Disease
    Accomando, Salvatore
    Liotta, Andrea
    Maggio, Maria Cristina
    Cardella, Francesca
    Corsello, Giovanni
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2010, 21 (07) : 1091 - 1092
  • [47] Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment
    Ko, Tai-Ming
    Kiyotani, Kazuma
    Chang, Jeng-Sheng
    Park, Jae-Hyun
    Yew, Poh Yin
    Chen, Yuan-Tsong
    Wu, Jer-Yuarn
    Nakamura, Yusuke
    HUMAN MOLECULAR GENETICS, 2018, 27 (15) : 2671 - 2677
  • [48] Effectiveness of Continuous Intravenous Infusion of Cyclosporine A for Patients With Intravenous Immunoglobulin-Resistant Kawasaki Disease
    Seki, Mitsuru
    Minami, Takaomi
    Anzai, Tatsuya
    Furui, Sadahiro
    Suzuki, Shun
    Sato, Tomoyuki
    Kataoka, Koichi
    Yamagata, Takanori
    CIRCULATION, 2019, 140
  • [49] Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease
    Lee, KY
    Han, JW
    Lee, JS
    Whang, KT
    ACTA PAEDIATRICA, 2002, 91 (02) : 164 - 167
  • [50] Utility of Ferritin as a Predictor of the Patients with Kawasaki Disease Refractory to Intravenous Immunoglobulin Therapy
    Yamamoto, Noboru
    Sato, Kaoru
    Hoshina, Takayuki
    Kojiro, Masumi
    Kusuhara, Koichi
    Kusuhara, Koichi
    CIRCULATION, 2015, 131
12345